Monitoring of tumor reoxygenation following irradiation by 31P magnetic resonance spectroscopy: An experimental study of human melanoma xenografts

Radiotherapy and Oncology

Volumn 52, Issue 3, 1999, Pages 261-267

  Olsen, Dag R ^a   Rofstad, Einar K ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b INSTITUTE OF CANCER RESEARCH   (Norway)

Author keywords

31P MRS; Bioenergetic status; Hypoxia; Melanoma xenografts; Reoxygenation

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CANCER RADIOTHERAPY; HUMAN; HUMAN CELL; MALE; MELANOMA; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REOXYGENATION; TREATMENT OUTCOME;

ANIMALS; CELL DEATH; CELL HYPOXIA; CELL SURVIVAL; ENERGY METABOLISM; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MELANOMA, AMELANOTIC; MICE; MICE, INBRED BALB C; MICE, NUDE; MONITORING, PHYSIOLOGIC; NEOPLASM TRANSPLANTATION; OXYGEN CONSUMPTION; PHOSPHATES; PHOSPHOCREATINE; PHOSPHORUS ISOTOPES; RADIOTHERAPY DOSAGE; TRANSPLANTATION, HETEROLOGOUS; TREATMENT FAILURE; TUMOR CELLS, CULTURED;

EID: 0032863711     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00075-4     Document Type: Article

References (47)

1. Abrams R.A. Recent developments in radiotherapy. Curr. Opin. Oncol. 4:1992;1099-1107.
2. Adams G.E., Bremner J.C., Counsell C.J., Stratford I.J., Thomas C., Wood P.J. Magnetic resonance spectroscopy studies on experimental murine and human tumors: comparison of changes in phosphorus metabolism with induced changes in vascular volume. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;467-471.
3. 31P NMR spectroscopy. NMR Biomed. 3:1990;178-183.
4. 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification. Br. J. Cancer. 64:1991;862-866.
5. Brizel D.M., Rosner G.L., Prosnitz L.R., Dewhirst M.W. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;1121-1125.
6. Brizel D.M., Sibley G.S., Prosnitz L.R., Scher R.L., Dewhirst M.W. Tumor hypoxia adversely affects the prognosis of carcinomas of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;285-289.
7. Courtenay V., Mills J. An in vitro colony assay for human tumours grown in immunesuppressed mice and treated in vivo with cytotoxic agents. Br. J. Cancer. 37:1978;261-268.
8. Daly P.F., Cohen J.S. Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. Cancer Res. 49:1989;770-779.
9. Evanochko W.T., Ng T.C., Glickson J.D. Application of in vivo NMR spectroscopy to cancer. Magn. Reson. Med. 1:1984;508-534.
10. Fenton B.M., Kiani M.F., Siemann D.W. Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? Int. J. Radiat. Oncol. Biol. Phys. 33:1995;365-373.
11. 31P NMR spectroscopy measurements, tumor size, hypoxic fraction and cell survival after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 18:1990;1341-1350.
12. Fyles A.W., Milosevic M., Wong R., et al. Hypoxia measured with a polarographic electrode correlates with radiation response in cervix cancer. Radiother. Oncol. 48:1998;149-156.
13. Gatenby R.A., Kessler H.B., Rosenblum J.S., Coia L.R., Moldofsky P.J., Hartz W.H., Broder G.J. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;831-838.
14. Gerweck L.E., Koutcher J.A., Zaidi S.T.H., Seneviratne T. Energy status in the murine FSaII and MCaIV tumors under aerobic and hypoxic conditions: an in-vivo and in-vitro analysis. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;557-561.
15. 2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 26:1993;45-50.
16. 2 tension measurements. Cancer Res. 51:1991;6098-6102.
17. Kallman R.F. The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology. 105:1972;135-142.
18. Kallman R.F., Dorie M.J. Tumor oxygenation and reoxygenation during radiation therapy: their importance in predicting tumor response. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;681-685.
19. Kim I.H., Lemmon M.J., Brown J.M. The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitro-imidazole binding. Radiat. Res. 135:1993;411-417.
20. 31P MRS. Magn. Reson. Imaging. 12:1994;109-119.
21. Koutcher J.A., Alfieri A.A., Devitt M.L., Rhee J.G., Kornblith A.B., Mahmood U., Merchant T.E., Cowburn D. Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation. Cancer Res. 52:1992;4620-4627.
22. 31P nuclear magnetic resonance spectroscopy. Cancer Res. 50:1990;7252-7256.
23. 31P NMR spectroscopy. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;1851-1855.
24. 31P nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood flow. Br. J. Cancer. 68:1993;1061-1070.
25. 31P nuclear magnetic resonance spectroscopy. Cancer Res. 54:1994;4885-4891.
26. Moulder J.E., Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys. 10:1984;695-712.
27. Nordsmark M., Bentzen S.M., Overgaard J. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter and intratumour heterogeneity. Acta Oncol. 33:1994;383-389.
28. Nordsmark M., Grau C., Horsman M.R., Jörgensen H.S., Overgaard J. Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model. Acta Oncol. 34:1995;329-334.
29. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41:1996;31-39.
30. Okunieff P., Walsh C.S., Vaupel P., Kallinowski F., Hitzig B.M., Neuringer L.J., Suit H. Effects of hydralazine on in vivo tumor energy metabolism, hematopoietic sensitivity, and cardiovascular parameters. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;1145-1148.
31. 31PMRS. Magn. Reson. Imaging. 15:1997;1187-1192.
32. 31PMRS. Magn. Reson. 1999.
33. Overgaard J. Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol. Res. 6:1994;509-518.
34. Rockwell S., Moulder J.E. Biological factors of importance in splitcourse radiotherapy. Paliwal B.R., Herbert D.E., Orton C.G. Optimization of Cancer Radiotherapy. 1985;171-182 American Institute of Physics, New York.
35. Rockwell S., Moulder J.E. Hypoxic fractions of human tumors xenografted into mice: a review. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;197-202.
36. Rofstad E.K. Radiation response of the cells of a human malignant melanoma xenograft. Effect of hypoxic cell radiosensitizers. Radiat. Res. 87:1981;670-683.
37. Rofstad E.K. Local tumor control following single dose irradiation of human melanoma xenografts: relationship to cellular radiosensitivity and influence of an immune response by the athymic mouse. Cancer Res. 49:1989;3163-3167.
38. Rofstad E.K. Hypoxia and reoxygenation in human melanoma xenografts. Int. J. Radiat. Oncol. Biol. Phys. 17:1989;81-89.
39. Rofstad E.K. NMR spectroscopy in prediction and monitoring of radiation response of tumours in vivo. Int. J. Radiat. Biol. 57:1990;1-5.
40. 31P nuclear magnetic resonance spectroscopy studies of tumour energy metabolism and its relationship to intracapillary oxyhemoglobin saturation and tumour hypoxia. Cancer Res. 48:1988;5440-5446.
41. Rofstad E.K., Wahl A., Stokke T., Nesland J.M. Establisment and characterization of six human melanoma xenograft lines. APMIS. 98:1990;945-953.
42. 31P nuclear magnetic resonance spectroscopy. Cancer Res. 47:1987;6467-6473.
43. 31P MR spectroscopy. Am. J. Roentgenol. 157:1991;243-248.
44. 31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;155-164.
45. 31P MRS observations of tumour energy metabolism. NMR Biomed. 5:1992;279-289.
46. 2 tension measurements. Cancer Res. 51:1991;3316-3322.
47. Wong R.K.W., Fyles A., Milosevic M., Pintlie M., Hill R.P. Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position and track depth. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;405-412.